Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 6269-6274, November 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valverius, E. M.
Right arrow Articles by Lippman, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valverius, E. M.
Right arrow Articles by Lippman, M. E.

Production of and Responsiveness to Transforming Growth Factor-ß in Normal and Oncogene-transformed Human Mammary Epithelial Cells1

Eva M. Valverius, Dorothy Walker-Jones, Susan E. Bates, Martha R. Stampfer, Robin Clark, Frank McCormick, Robert B. Dickson2 and Marc E. Lippman

Vincent Lombardi Cancer Research Center, Georgetown University Hospital, Washington DC 20007 [E. M. V., M. E. L., R. B. D.]; Department of Zoology, Howard University, Washington DC 20059 [D. W. J.]; Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 [S. E. B.]; Lawrence Berkeley Laboratory, Berkeley, California 94720 [M. R. S.]; and Cetus Corporation, Emeryville, California 94608 [R. C., F. M.]

Transforming growth factors-ß (TGFß) are a family of closely related, ubiquitously expressed growth factors with the common properties of induction of growth inhibition and expression of differentiation-related markers in epithelial cells. We investigated the role of TGFß1 in growth regulation of normal human mammary epithelial cells and in benzo(a)pyrene immortalized sublines further transformed by oncogenes in retroviral vectors. The normal cells were markedly growth inhibited by TGFß1, produced TGFß in a latent form, and expressed TGFß receptors. In the immortalized cells, both TGFß-induced growth inhibition and TGFß receptor binding were reduced. With the single oncogenes v-Ha-ras, v-mos, and SV40 T, growth sensitivity to TGFß1 increased, but TGFß production or TGFß receptor expression was not altered. Transformation to full malignancy by both SV40 T and v-Ha-ras led to escape from growth inhibition by TGFß under anchorage-independent, but not anchorage-dependent, conditions without affecting TGFß production or receptor characteristics. Thus, modulation of TGFß growth responsiveness in these normal and oncogene transformed human mammary epithelial cells apparently occurs at a level distal to TGFß receptor binding and is not solely correlated to expression of transforming oncogenes. Further, modulation of TGFß production is not an indicator of malignant transformation in this system.

1 Supported by NIH Grant CA-24844, and the Office of Energy Research, Office of Health and Environmental Research of the U. S. Department of Energy, (Contract DE-AC03-76SF00098).

2 To whom requests for reprints should be addressed, at Vincent Lombardi Cancer Research Center, Georgetown University Hospital, 3900 Reservoir Road NW, Washington DC 20007.

Received 1/ 5/89. Revised 6/ 9/89. Revised 8/16/89. Accepted 8/21/89.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Horiguchi, T. Shirakihara, A. Nakano, T. Imamura, K. Miyazono, and M. Saitoh
Role of Ras Signaling in the Induction of Snail by Transforming Growth Factor-{beta}
J. Biol. Chem., January 2, 2009; 284(1): 245 - 253.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. I. Berndt, W.-Y. Huang, N. Chatterjee, M. Yeager, R. Welch, S. J. Chanock, J. L. Weissfeld, R. E. Schoen, and R. B. Hayes
Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma
Carcinogenesis, September 1, 2007; 28(9): 1965 - 1970.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Calonge and J. Massague
Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-beta Antiproliferative Responses in Colon Cancer Cells
J. Biol. Chem., November 19, 1999; 274(47): 33637 - 33643.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
M. A. Sovak, M. Arsura, G. Zanieski, K. T. Kavanagh, and G. E. Sonenshein
The Inhibitory Effects of Transforming Growth Factor {beta}1 on Breast Cancer Cell Proliferation Are Mediated through Regulation of Aberrant Nuclear Factor-{{kappa}}B/Rel Expression
Cell Growth Differ., August 1, 1999; 10(8): 537 - 544.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
M. Kretzschmar, J. Doody, I. Timokhina, and J. Massagué
A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras
Genes & Dev., April 1, 1999; 13(7): 804 - 816.
[Abstract] [Full Text]


Home page
JCOHome page
Y. Maehara, Y. Kakeji, A. Kabashima, Y. Emi, A. Watanabe, K. Akazawa, H. Baba, S. Kohnoe, and K. Sugimachi
Role of Transforming Growth Factor-{beta}1 in Invasion and Metastasis in Gastric Carcinoma
J. Clin. Oncol., February 1, 1999; 17(2): 607 - 607.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Stoica, M. Saceda, A. Fakhro, H. B. Solomon, B. D. Fenster, and M. B. Martin
The Role of Transforming Growth Factor-{beta} in the Regulation of Estrogen Receptor Expression in the MCF-7 Breast Cancer Cell Line
Endocrinology, April 1, 1997; 138(4): 1498 - 1505.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Koli, T. T. Ramsey, Y. Ko, T. C. Dugger, M. G. Brattain, and C. L. Arteaga
Blockade of Transforming Growth Factor-beta Signaling Does Not Abrogate Antiestrogen-induced Growth Inhibition of Human Breast Carcinoma Cells
J. Biol. Chem., March 28, 1997; 272(13): 8296 - 8302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. L. Woo, H. H. Cha, K. L. Singer, and G. L. Firestone
Antagonistic Regulation of Tight Junction Dynamics by Glucocorticoids and Transforming Growth Factor-beta in Mouse Mammary Epithelial Cells
J. Biol. Chem., January 5, 1996; 271(1): 404 - 412.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. L. Segev, T. U. Ha, T. T. Tran, M. Kenneally, P. Harkin, M. Jung, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFkappa B-mediated Pathway
J. Biol. Chem., September 8, 2000; 275(37): 28371 - 28379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Fanayan, S. M. Firth, A. J. Butt, and R. C. Baxter
Growth Inhibition by Insulin-like Growth Factor-binding Protein-3 in T47D Breast Cancer Cells Requires Transforming Growth Factor-beta (TGF-beta ) and the Type II TGF-beta Receptor
J. Biol. Chem., December 8, 2000; 275(50): 39146 - 39151.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.